• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[阿尔茨海默病及其他痴呆症的流行病学]

[Epidemiology of Alzheimer's disease and other dementias].

作者信息

Garre-Olmo J

机构信息

Hospital de Santa Caterina. Institut d'Assistencia Sanitaria, Salt, Espana.

出版信息

Rev Neurol. 2018 Jun 1;66(11):377-386.

PMID:29790571
Abstract

INTRODUCTION

Dementia is a clinical syndrome resulting from a number of causations and which is usually accompanied by progressive and diffuse brain dysfunction. The different subtypes are characterised by a clinical picture with common symptoms that differ in terms of their aetiology, age, clinical presentation, clinical course and associated disorders.

AIM

To present an update on the information available about the descriptive epidemiology of dementia and its main subtypes.

DEVELOPMENT

The main data on prevalence, incidence and mortality were extracted from a literature review. Alzheimer's disease is the most frequent subtype and accounts for 60-80% of all the cases, followed by vascular dementia and other neurodegenerative dementias, such as dementia due to Lewy bodies, the dementia-Parkinson complex and frontotemporal dementia. Other subtypes of dementias present frequencies below 1%, and the epidemiological indicators available are not very robust.

CONCLUSIONS

The prevalence and incidence of dementia increase exponentially from the age of 65 onwards. As a consequence of the progressive ageing of the population and the increase in life expectancy, the number of cases of dementia will rise in the coming decades. Recent studies point to a slight drop in the accumulated risk of dementia adjusted by age groups and sex over the last few decades in some countries. It is possible that by means of primary prevention strategies implemented upon the known risk factors for dementia the burden of dementia on public health will diminish in the future.

摘要

引言

痴呆是一种由多种病因引起的临床综合征,通常伴有进行性和弥漫性脑功能障碍。不同亚型的特征是临床表现具有共同症状,但其病因、年龄、临床表现、临床病程及相关疾病有所不同。

目的

介绍有关痴呆及其主要亚型描述性流行病学的现有信息更新情况。

进展

患病率、发病率和死亡率的主要数据来自文献综述。阿尔茨海默病是最常见的亚型,占所有病例的60%-80%,其次是血管性痴呆和其他神经退行性痴呆,如路易体痴呆、痴呆-帕金森综合征和额颞叶痴呆。其他痴呆亚型的出现频率低于1%,现有的流行病学指标不太可靠。

结论

痴呆的患病率和发病率从65岁起呈指数增长。由于人口的逐渐老龄化和预期寿命的增加,未来几十年痴呆病例数将会上升。最近的研究表明,在过去几十年中,一些国家按年龄组和性别调整后的痴呆累积风险略有下降。通过针对已知痴呆风险因素实施一级预防策略,未来痴呆对公共卫生的负担可能会减轻。

相似文献

1
[Epidemiology of Alzheimer's disease and other dementias].[阿尔茨海默病及其他痴呆症的流行病学]
Rev Neurol. 2018 Jun 1;66(11):377-386.
2
Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer's disease and other dementias.衰老及相关认知障碍的流行病学:阿尔茨海默病和其他痴呆症的患病率及发病率
Handb Clin Neurol. 2019;167:139-148. doi: 10.1016/B978-0-12-804766-8.00009-1.
3
Epidemiology of age-related dementias in the Third World and aetiological clues of Alzheimer's disease.第三世界国家与年龄相关的痴呆症流行病学及阿尔茨海默病的病因线索
Trop Geogr Med. 1991 Oct;43(4):345-51.
4
[Frequency of different forms of dementia at the Department of Neuropathology of the Hungarian National Institute of Psychiatry and Neurology during a 3-year period].[匈牙利国家精神病学与神经病学研究所神经病理学系三年期间不同类型痴呆症的发病率]
Ideggyogy Sz. 2008 Jan 30;61(1-2):24-32.
5
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis.中国 1990-2010 年阿尔茨海默病和其他形式痴呆的流行病学:系统回顾和分析。
Lancet. 2013 Jun 8;381(9882):2016-23. doi: 10.1016/S0140-6736(13)60221-4.
6
Dementias.痴呆症
Handb Clin Neurol. 2016;138:123-51. doi: 10.1016/B978-0-12-802973-2.00008-2.
7
The epidemiology of the dementias: an update.痴呆症的流行病学:最新进展。
Curr Opin Psychiatry. 2007 Jul;20(4):380-5. doi: 10.1097/YCO.0b013e32816ebc7b.
8
Epidemiology of dementias and Alzheimer's disease.痴呆症和阿尔茨海默病的流行病学。
Arch Med Res. 2012 Nov;43(8):600-8. doi: 10.1016/j.arcmed.2012.11.003. Epub 2012 Nov 15.
9
Subtypes of depression among patients with Alzheimer's disease and other dementias.阿尔茨海默病和其他痴呆症患者的抑郁症亚型。
Alzheimers Dement. 2010 Jan;6(1):63-9. doi: 10.1016/j.jalz.2009.04.1232.
10
Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.阿尔茨海默病和非阿尔茨海默病性痴呆中步态障碍的患病率和严重程度。
J Am Geriatr Soc. 2005 Oct;53(10):1681-7. doi: 10.1111/j.1532-5415.2005.53552.x.

引用本文的文献

1
Impact of Manganese on Neuronal Function: An Exploratory Multi-Omics Study on Ferroalloy Workers in Brescia, Italy.锰对神经元功能的影响:意大利布雷西亚铁合金工人的探索性多组学研究
Brain Sci. 2025 Jul 31;15(8):829. doi: 10.3390/brainsci15080829.
2
Integrative machine learning approach to risk prediction for dementia and Alzheimer's disease.用于痴呆症和阿尔茨海默病风险预测的综合机器学习方法。
Geroscience. 2025 Aug 27. doi: 10.1007/s11357-025-01828-x.
3
AI-guided patient stratification improves outcomes and efficiency in the AMARANTH Alzheimer's Disease clinical trial.
在AMARANTH阿尔茨海默病临床试验中,人工智能引导的患者分层改善了治疗效果和效率。
Nat Commun. 2025 Jul 17;16(1):6244. doi: 10.1038/s41467-025-61355-3.
4
Genetic insights into the association between inflammatory bowel disease and Alzheimer's disease.炎症性肠病与阿尔茨海默病关联的遗传学见解。
Genes Immun. 2025 Jul 16. doi: 10.1038/s41435-025-00344-4.
5
Digital Health Literacy and Physical Activity Programme for Improvement of Quality of Life in Caregivers of People with Dementia (CAREFIT): Study Protocol.改善痴呆症患者照料者生活质量的数字健康素养与身体活动计划(CAREFIT):研究方案
Healthcare (Basel). 2025 May 22;13(11):1219. doi: 10.3390/healthcare13111219.
6
Causal relationship between proton pump inhibitors and dementia risk: evidence from a Mendelian randomization study.质子泵抑制剂与痴呆风险之间的因果关系:来自孟德尔随机化研究的证据。
Eur Arch Psychiatry Clin Neurosci. 2025 Jun 7. doi: 10.1007/s00406-025-02036-6.
7
Impact of Manganese on Neuronal Function: An Exploratory MultiOmic Study on Ferroalloy Workers in Brescia, Italy.锰对神经元功能的影响:意大利布雷西亚铁合金工人的一项探索性多组学研究。
medRxiv. 2025 May 6:2025.05.02.25326824. doi: 10.1101/2025.05.02.25326824.
8
Stilbenes Against Alzheimer's Disease: A Comprehensive Review of Preclinical Studies of Natural and Synthetic Compounds Combined with the Contributions of Developed Nanodrug Delivery Systems.芪类化合物抗阿尔茨海默病:天然及合成化合物临床前研究综述以及新型纳米药物递送系统的贡献
Molecules. 2025 Apr 29;30(9):1982. doi: 10.3390/molecules30091982.
9
Commonly prescribed multi-medication therapies exert sex-specific effects on Alzheimer's disease pathology and metabolomic profiles in App mice: Implications for personalized therapeutics in aging.常用的多药联合疗法对App小鼠的阿尔茨海默病病理和代谢组学特征具有性别特异性影响:对衰老个性化治疗的启示。
Alzheimers Dement. 2025 Mar;21(3):e70081. doi: 10.1002/alz.70081.
10
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances.神经退行性疾病的抗衰老策略:从机制到临床进展
Signal Transduct Target Ther. 2025 Mar 10;10(1):76. doi: 10.1038/s41392-025-02145-7.